Form 4 for CTKB Cytek Biosciences, Inc.
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001209191-23-016979 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-07 | 2023-03-07 | CTKB | Jiang Wenbin | Pres, CEO, Dir | S - Sale | $10.13 | -20.0K | 7.70M | -0.3% | -$202.6K |
| DM | 2023-03-07 | 2023-03-03 | CTKB | Jiang Wenbin | Pres, CEO, Dir | A - Grant | $0.00 | +473.4K | 284.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-07 | S | D | 20,000 | $10.13 | 7,704,439 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 2 | Derivative | Restricted Stock Units | 2023-03-03 | A | A | 188,501 | $0.00 | 188,501 | D | — · — to — | 188,501 Common Stock | (F4) Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock. (F5) The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2023-03-03 | A | A | 284,900 | $0.00 | 284,900 | D | $10.61 · — to 2033-03-03 | 284,900 Common Stock | (F3) 1/48th of the shares subject to the option shall vest monthly over four years from the vesting commencement date of March 3, 2023. The option becomes fully vested on March 3, 2027. |